BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30138762)

  • 1. Reducing harms from treatment. Sixteen years of surgery of the axilla for screen-detected breast cancers in Italy.
    Lazzaretti MG; Ponti A; Mano MP; Barca A; Casella D; Frigerio A; Giordano L; Mantellini P; Paduos A; Pitarella S; Ravaioli A; Taffurelli M; Tomatis M; Segnan N
    Breast; 2018 Dec; 42():15-22. PubMed ID: 30138762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in the management of the axilla in screen-detected ductal carcinoma in situ: evidence from the UK NHS breast screening programme audit of screen detected DCIS.
    Nicholson S; Hanby A; Clements K; Kearins O; Lawrence G; Dodwell D; Bishop H; Thompson A;
    Eur J Surg Oncol; 2015 Jan; 41(1):86-93. PubMed ID: 25441934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A single-center retrospective study on axillary evaluation in 1 557 breast ductal carcinoma in situ patients between 2006 and 2016].
    Si J; Quan CL; Mo M; Guo R; Su YH; Yang BL; Chen JJ; Shao ZM; Wu J
    Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):681-685. PubMed ID: 31474060
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
    Pyfer BJ; Jonczyk M; Jean J; Graham RA; Chen L; Chatterjee A
    Ann Surg Oncol; 2020 Sep; 27(9):3448-3455. PubMed ID: 32232706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does sentinel lymph node biopsy for screening high-grade ductal carcinoma in situ of the breast cause more harm than good?
    Ramzi S; Najeeb E; Coulthard J; Jenkins S
    Breast Cancer Res Treat; 2020 Jul; 182(1):47-54. PubMed ID: 32430678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
    Coromilas EJ; Wright JD; Huang Y; Feldman S; Neugut AI; Chen L; Hershman DL
    JAMA Oncol; 2015 Jun; 1(3):323-32. PubMed ID: 26181180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second biopsy of axillary sentinel lymph node for reappearing breast cancer after previous sentinel lymph node biopsy.
    Intra M; Trifirò G; Viale G; Rotmensz N; Gentilini OD; Soteldo J; Galimberti V; Veronesi P; Luini A; Paganelli G; Veronesi U
    Ann Surg Oncol; 2005 Nov; 12(11):895-9. PubMed ID: 16195833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ.
    Magnoni F; Massari G; Santomauro G; Bagnardi V; Pagan E; Peruzzotti G; Galimberti V; Veronesi P; Sacchini VS
    Br J Surg; 2019 Mar; 106(4):375-383. PubMed ID: 30791092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.
    Huang NS; Si J; Yang BL; Quan CL; Chen JJ; Wu J
    Cancer Med; 2018 Jan; 7(1):56-63. PubMed ID: 29271113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast; 2014 Feb; 23(1):63-8. PubMed ID: 24291376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
    Shin YD; Lee HM; Choi YJ
    BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International variation in management of screen-detected ductal carcinoma in situ of the breast.
    Ponti A; Lynge E; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Mano MP; Kawai M; Scharpantgen A; Fracheboud J; Hofvind S; Vidal C; Ascunce N; Salas D; Bulliard JL; Segnan N; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Oct; 50(15):2695-704. PubMed ID: 25149183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.
    Hotton J; Salleron J; Rauch P; Buhler J; Pierret M; Baumard F; Leufflen L; Marchal F
    J Gynecol Obstet Hum Reprod; 2020 Mar; 49(3):101641. PubMed ID: 31562936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
    Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
    Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
    Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
    Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
    Murthy V; Chamberlain RS
    Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
    Heymans C; van Bastelaar J; Visschers RGJ; Vissers YLJ
    Clin Breast Cancer; 2017 Jun; 17(3):e87-e93. PubMed ID: 28162949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.